$4.07
-0.13 (-2.98%)
Open$4.34
Previous Close$4.20
Day High$4.39
Day Low$4.02
52W High$9.08
52W Low$1.08
Volume—
Avg Volume537.5K
Market Cap187.37M
P/E Ratio—
EPS$-4.11
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 184.51M | 172.01M | 149.83M |
| Net Income | 6.70M | 5.27M | 5.04M |
| Profit Margin | 3.6% | 3.1% | 3.4% |
| EBITDA | 12.90M | 10.88M | 9.08M |
| Free Cash Flow | 3.45M | 3.47M | 2.49M |
| Rev Growth | +0.4% | +18.6% | +9.2% |
| Debt/Equity | 0.16 | 0.19 | 0.18 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $261.07 | +3.99% | 126.9 | 461.26B |
| AMGN | Amgen Inc | $374.15 | +3.55% | 25.9 | 201.93B |
| GILD | Gilead Sciences Inc | $131.27 | +4.21% | 17.7 | 162.98B |
| VRTX | Vertex Pharmaceuticals Inc | $528.04 | +6.03% | 30.4 | 131.79B |
| REGN | Regeneron Pharmaceuticals | $654.27 | +4.73% | 15.5 | 68.59B |
| ALNY | Alnylam Pharmaceuticals Inc | $312.78 | +3.68% | 72.4 | 41.76B |